Peloid Therapy in Temporomandibular Joint Dysfunction
The Effect of Peloid Therapy on Pain and Functional Outcomes in Patients With Temporomandibular Joint Dysfunction
研究概览
详细说明
Temporomandibular joint dysfunction is associated with pain, impaired chewing, restricted jaw function, and, in some patients, referred otalgia. Conservative treatment options are commonly used as first-line management, but the clinical evidence for some physical therapy modalities remains limited.
Peloid therapy is a local thermotherapeutic intervention used in balneotherapy and physical medicine. It may provide analgesic and muscle-relaxing effects through superficial heat and local tissue responses. However, prospective data evaluating its clinical effect in temporomandibular joint dysfunction are limited.
This study is designed to assess changes in jaw-related functional limitation and pain after a standardized 2-week course of local peloid therapy in adults diagnosed with temporomandibular joint dysfunction. Functional status, pain intensity, mouth opening, symptom severity, and secondary otalgia will be assessed before and after treatment using standardized clinical measures.
The study may provide additional evidence on the role of peloid therapy as a conservative supportive treatment option for temporomandibular joint dysfunction.
研究类型
注册 (估计的)
阶段
- 不适用
联系人和位置
学习联系方式
- 姓名：Faruk Kadri Bakkal, MD, Asistant Professor
- 电话号码：4238 +90 276 224 00 00
- 邮箱：fkbakkal@gmail.com
学习地点
-
-
Merkez
-
Uşak、Merkez、土耳其（türkiye）、64420
- 招聘中
- Uşak University Faculty of Medicine
-
接触：
- Faruk Kadri Bakkal
- 电话号码：4238 +90 276 224 00 00
- 邮箱：fkbakkal@gmail.com
-
-
参与标准
资格标准
适合学习的年龄
- 成人
- 年长者
接受健康志愿者
描述
Inclusion Criteria:
- Age between 18 and 65 years
- Diagnosis of temporomandibular joint dysfunction based on DC/TMD criteria
- Presence of TMJ-related pain for at least 4 weeks
- Baseline pain intensity ≥3 on a 0-10 visual analog scale
- Ability to provide written informed consent
Exclusion Criteria:
- History of temporomandibular joint trauma, tumor, active infection, or acute inflammation
- Previous temporomandibular joint surgery
- Presence of systemic inflammatory rheumatologic disease
- Pregnancy
- Open wound, active dermatitis, or skin condition preventing peloid application at the treatment site
- Injection therapy (e.g., botulinum toxin) or regular physical therapy for TMJ within the past 3 months
- Any clinical or behavioral condition that may interfere with study compliance
学习计划
研究是如何设计的？
设计细节
- 主要用途：治疗
- 分配：不适用
- 介入模型：单组作业
- 屏蔽：无（打开标签）
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的：Peloid Therapy
|
Participants will receive local peloid therapy applied externally over the temporomandibular joint region and adjacent masticatory muscles.
The treatment will be delivered as 10 sessions over 2 weeks, with 5 sessions per week.
Each session will last 20 minutes.
Peloid therapy will be administered by a trained investigator according to the study protocol.
|
研究衡量的是什么？
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Change in Jaw Function Score at Week 2
大体时间：Baseline and Week 2
|
Jaw function will be assessed using the Jaw Functional Limitation Scale-8 (JFLS-8).
This is a patient-reported questionnaire that measures limitation in jaw activities such as chewing, speaking, and mouth opening.
The total score ranges from 0 to 10, where 0 indicates no functional limitation and 10 indicates the highest level of limitation.
The primary outcome will be the change in JFLS-8 total score from baseline to Week 2.
|
Baseline and Week 2
|
合作者和调查者
出版物和有用的链接
一般刊物
- Schiffman E, Ohrbach R, Truelove E, Look J, Anderson G, Goulet JP, List T, Svensson P, Gonzalez Y, Lobbezoo F, Michelotti A, Brooks SL, Ceusters W, Drangsholt M, Ettlin D, Gaul C, Goldberg LJ, Haythornthwaite JA, Hollender L, Jensen R, John MT, De Laat A, de Leeuw R, Maixner W, van der Meulen M, Murray GM, Nixdorf DR, Palla S, Petersson A, Pionchon P, Smith B, Visscher CM, Zakrzewska J, Dworkin SF; International RDC/TMD Consortium Network, International association for Dental Research; Orofacial Pain Special Interest Group, International Association for the Study of Pain. Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) for Clinical and Research Applications: recommendations of the International RDC/TMD Consortium Network* and Orofacial Pain Special Interest Groupdagger. J Oral Facial Pain Headache. 2014 Winter;28(1):6-27. doi: 10.11607/jop.1151.
- Sun R, Liu T, Liu Y, Zhang S, Yue Y, Jiang N, Zhang L, Xiong X. Simplified Jaw Functional Limitation Scale for Temporomandibular Disorders: Psychometric Evaluation. Oral Dis. 2025 Jun;31(6):1854-1860. doi: 10.1111/odi.15253. Epub 2025 Jan 10.
- Ramazani F, Szalay-Anderson C, Batista AV, Park P, Hwang E, Chau J, Lui J. Referred otalgia: Common causes and evidence-based strategies for assessment and management. Can Fam Physician. 2023 Nov;69(11):757-761. doi: 10.46747/cfp.6911757.
- Kuttila SJ, Kuttila MH, Niemi PM, Le Bell YB, Alanen PJ, Suonpaa JT. Secondary otalgia in an adult population. Arch Otolaryngol Head Neck Surg. 2001 Apr;127(4):401-5. doi: 10.1001/archotol.127.4.401.
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他相关的 MeSH 术语
其他研究编号
- PT-TMJ
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)？
IPD 计划说明
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索，没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求，请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改，我们的网站上也会自动更新.